PDCD1 and neoplasm: In this experimental model, treatment with either anti-PD-1 antibody or MMP2 inhibitor alone significantly reduced tumor growth, while a combination treatment of MMP2 inhibitor and anti-PD-1 antibody achieved the best efficacy (Fig. 5B).